Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size Syndrome

NCT07276568 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ENROLLING_BY_INVITATION

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Small-for-size Syndrome

Interventions

DRUG: Hepatocyte-like cell administration via rectus sheath intramuscular injection

Sponsor

Zhi-Jun Zhu